Skip to content

Evofem Biosciences

5 viewers · 30d

Total raised

$1.7M

2 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $925K
ROUNDS
2
INVESTORS
1
FOUNDED
N/A
HQ
San Diego, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
5

AI overview

Updated

Evofem Biosciences, Inc. is a biopharmaceutical company focused on women's sexual and reproductive health. They develop and commercialize hormone-free, patient-controlled solutions, providing women with greater control over their health choices. The company addresses unmet needs in contraception, vaginal infections, and sexually transmitted infections.

What sets it apart

Hormone-free, patient-controlled solutions

Funding history

2 rounds
Equity+1Jun 26, 2025
Form D
+$925K$1.7M total
Equity+1Apr 8, 2025
Form D
+$750K$750K total

Products

1 tracked

Phexxi

Contraceptive vaginal gel

Phexxi is the first and only FDA-approved, hormone-free, on-demand contraceptive vaginal gel. Using a proprietary vaginal pH modulator, it is applied 0-60 minutes before intercourse to maintain a slightly acidic vaginal environment, which helps prevent sperm from fertilizing an egg.

  • Hormone-free
  • Easy-to-use
  • Non-invasive
  • On-demand contraception

Links

WebsiteSEC EDGAR filings